Key result
Huoxue Tongmai formula attenuates cardiac dysfunction and remodeling in TAC-induced hypertrophy by enhancing mitophagy.
Why the study?
Does Huoxue Tongmai formula (XMT) ameliorate pressure overload-induced cardiac hypertrophy and dysfunction in a murine model and Ang II-stimulated cardiomyocytes?
Does Huoxue Tongmai formula (XMT) ameliorate pressure overload-induced cardiac hypertrophy and dysfunction in a murine model and Ang II-stimulated cardiomyocytes?
Answers are grounded in this paper and cite their sources.
Preclinical findings demonstrate that Huoxue Tongmai formula alleviates pressure overload-induced cardiac hypertrophy and dysfunction by restoring mitophagy and mitochondrial respiration while suppressing ferroptosis.
Huoxue Tongmai formula (XMT), a hospital-prepared traditional Chinese medicine formulation, has demonstrated clinical efficacy against cardiovascular diseases. However, its mechanisms in ameliorating myocardial hypertrophy remain incompletely understood. This study aimed to investigate the cardioprotective effects of XMT in a murine model of pressure overload-induced cardiac hypertrophy and to elucidate the underlying molecular mechanisms. Bioactive constituents of XMT were characterized using HPLC-Q-TOF-MS/MS. In vivo assessments were conducted in a transverse aortic constriction (TAC)-induced cardiac hypertrophy mouse model, followed by transcriptomic profiling to identify differentially regulated pathways. In vitro experiments using angiotensin II (Ang II)-stimulated cardiomyocyte hypertrophy were performed to validate the protective effects and mechanisms of XMT. XMT administration significantly ameliorated TAC-induced cardiac dysfunction, as evidenced by improved echocardiographic parameters (LVEF, LVFS, and SV), as well as attenuated ventricular wall thickening and cardiac mass enlargement. XMT also reduced myocardial injury, interstitial fibrosis, and serum levels of NT-proBNP, cTn-T, CK-MB, and LDH. Notably, XMT suppressed pathological hypertrophic remodeling, reflected by decreased HW/TL and HW/BW ratios, reduced cardiomyocyte cross-sectional area, and downregulated expression of hypertrophic marker genes (Nppa, Nppb, and MYH7). Transcriptomic analysis revealed that XMT modulated pathways associated with mitochondrial function, oxidative phosphorylation, and mitophagy. Mechanistically, XMT upregulated the mitophagy regulators PINK1, Parkin, and FUNDC1, attenuated mitochondrial reactive oxygen species (ROS) production, and preserved mitochondrial DNA (mtDNA) content. Moreover, XMT suppressed ferroptosis in hypertrophic hearts, as evidenced by increased GSH content, elevated GPX4 and SLC7A11 expression, and reduced MDA, total iron, and PTGS2 levels. In vitro, XMT exerted protective effects against Ang II-induced cardiomyocyte hypertrophy, as demonstrated by enhanced cell viability, reduced LDH release, preserved mitochondrial membrane potential (ΔΨm), and marked suppression of mitochondrial ROS generation. XMT-medicated serum also attenuated Ang II-induced lipid peroxidation as measured by C11-BODIPY assay. Moreover, Seahorse-based metabolic flux analysis indicated that XMT significantly improved mitochondrial respiratory function, evidenced by elevated basal and maximal oxygen consumption rates (OCR). Concurrently, XMT attenuated the compensatory upregulation of glycolysis, as shown by a reduced extracellular acidification rate (ECAR) and diminished glycolytic reserve. Collectively, these findings demonstrate that XMT alleviates pressure overload-induced cardiac hypertrophy by enhancing mitochondrial respiration and promoting mitophagy, positioning it as a promising therapeutic candidate for hypertrophic heart failure.
No takes yet. Share an insight, caveat, or question.
Lian et al. (2026) studied Pressure overload-induced cardiac hypertrophy and heart failure. Huoxue Tongmai formula (XMT) was evaluated on Cardiac function (LVEF, LVFS, SV) and pathological hypertrophic remodeling. Huoxue Tongmai formula ameliorated TAC-induced cardiac dysfunction (improving LVEF, LVFS, SV) and hypertrophic remodeling by enhancing mitophagy, oxidative phosphorylation, and suppressing ferroptosis.
Synapse has enriched 10 related papers. Consider them for comparative context: